DR. REDDY’S INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Dr. Reddy’s Laboratories Ltd. for Possible Securities Fraud

NEW ORLEANS--()--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Dr. Reddy’s Laboratories Ltd. (NYSE: RDY).

On November 6, 2015, Dr. Reddy's disclosed that the Company received a "warning letter" from the United States Food and Drug Administration over inadequate quality controls at three manufacturing plants producing drugs for cancer and other diseases and that it was undertaking an initiative to revamp the Company’s quality controls.

On this news, the price of Dr. Reddy’s stock plummeted.

KSF’s investigation is focusing on whether Dr. Reddy’s and/or its officers and directors violated state or federal securities laws.

If you are a Dr. Reddy’s shareholder who has suffered losses or have information that would assist KSF in its investigation, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com).

About Kahn Swick & Foti, LLC

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.


Kahn Swick & Foti, LLC
Lewis Kahn, 1 877-515-1850
Managing Partner

Recent Stories

RSS feed for Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC